Arrhythmogenic right ventricular dysplasia natural history
Arrhythmogenic right ventricular dysplasia Microchapters |
Differentiating Arrhythmogenic right ventricular dysplasia from other Diseases |
---|
Diagnosis |
Treatment |
Arrhythmogenic right ventricular dysplasia natural history On the Web |
American Roentgen Ray Society Images of Arrhythmogenic right ventricular dysplasia natural history |
FDA on Arrhythmogenic right ventricular dysplasia natural history |
CDC on Arrhythmogenic right ventricular dysplasia natural history |
Arrhythmogenic right ventricular dysplasia natural history in the news |
Blogs onArrhythmogenic right ventricular dysplasia natural history |
Directions to Hospitals Treating Arrhythmogenic right ventricular dysplasia |
Risk calculators and risk factors for Arrhythmogenic right ventricular dysplasia natural history |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Natural History
There is a long asymptomatic lead-time in individuals with ARVD. While this is a genetically transmitted disease, individuals in their teens may not have any characteristics of ARVD on screening tests.
Many individuals have symptoms associated with ventricular tachycardia, such as palpitations, light-headedness, or syncope. Others may have symptoms and signs related to right ventricular failure, such as lower extremity edema, liver congestion with elevated hepatic enzymes. Unfortunately, sudden death may be the first manifestation of disease.
ARVD is a progressive disease. Over time, the right ventricle becomes more involved, leading to right ventricular failure. The right ventricle will fail before there is left ventricular dysfunction. However, by the time the individual has signs of overt right ventricular failure, there will be histological involvement of the left ventricle. Eventually, the left ventricle will also become involved, leading to bi-ventricular failure. Signs and symptoms of left ventricular failure may become evident, including congestive heart failure, atrial fibrillation, and an increased incidence of thromboembolic events.